Confirmed Investors

RESI Boston September 2025 Confirmed Investors

Alumni Ventures

AstraZeneca

Asymmetry Ventures

Chugai Venture Fund

Danaher Corporation

Flare Capital Partners

FUJIFILM Corporation

Hevolution Foundation

Kissei Pharmaceutical Co., Ltd

MilliporeSigma

MVM Life Science Partners

Myriad Genetics

Otsuka Pharmaceutical Co., Ltd.

Philips Healthcare

Sanofi

Shimadzu Corporation

Siemens Healthineers

Taiho Ventures

Tosoh Corporation

Xontogeny

1435 Capital Management

5Y Captital

82VS

Advantary Capital Partners

Angel Star Ventures

Asahi Intecc USA

Asahi Kasei Pharma Corporation

Atlas Capital Ventures

AutoBio Venture Capital

Avicella Capital

Back Bay Group

Bayland Capital

Big Tree Innovation Fund

Bio 9 Ventures

Biocytogen

BioGenerator Ventures

BioIdeations

Bold Brain Capital

Boston Harbor Angels

Breakthrough T1D

Cell and Gene Therapy Catapult

CKD USA

Covenant Venture Capital

CS Ventures

Curie.Bio

Desire Ventures

Device of Tomorrow Capital

EA Pharma

Esplanade HealthTech Ventures

Evolutia Venture Partners

FoundersX

FoxHIll Asset Management

Gaingels

H Tree Capital

Health Innovation Capital

HelixPoint Capital

Hub Angels Investment Group

IHM-GBA

K2 Venture Partners

Kerna Ventures

Kidron Capital

LAFANA

Launchpad Venture Group

Life Science Angels

LifeSpan Vision Ventures

Liftt

Mass Medical Angels

MDB Capital

Mediqventures

Mid Atlantic Bio Angels

Myeloma Investment Fund

Nipro Medical Corporation

Niterra Ventures

Northlea Parnters

Novaterra

P74 Ventures

Pacific Bridge NY

Pathos AI

Pharma Capital Partners

PsyMed Ventures

Pureland Global Venture

Raise Health

RCP Venture Capital

RYSE

Santen

Seae Ventures

Sila B Health Ventures

Sumitomo Bakelite

Sumitomo Pharma Co., Ltd.

T.Rx Capital

Taiwan Global Angels (TGA)

Technomark Life Sciences

Teijin Pharma

Teikoku Ventures, Inc. (TVI)

The Venture Collective

uBriGene Biosciences Inc.

WuXi Biologics Healthcares Venture

Xcellerant Ventures